September 29, 2017 / 6:05 AM / 18 days ago

BRIEF-Elanix Biotechnologies H1 ‍total revenue of EUR 77,847

Sept 29 (Reuters) - ELANIX BIOTECHNOLOGIES AG:

* H1 ‍TOTAL REVENUE OF EUR 77,847 COMPARED TO EUR 0 IN FIRST HALF 2016​

* H1 ‍OPERATING LOSS OF EUR 1,976,839​

* ‍H1 CASH AND CASH EQUIVALENTS OF EUR 2,284,544 (COMPARED TO EUR 73,581 AS OF DECEMBER 31, 2016)​

* ‍REAFFIRMS ITS FINANCIAL GUIDANCE FOR 2017 AS PUBLISHED IN 2016 ANNUAL REPORT​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below